Fairmount Funds Management is a Philadelphia-based investment firm.
Fairmount Funds Management is a Philadelphia-based investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2022
Apogee Therapeutics
|
Series B | $149M | Biotechnology | — |
Aug 12, 2022
Terns Pharmaceuticals
|
Post-IPO Equity | $65M | Biotechnology | Yes |
Jan 1, 2022
Apogee Therapeutics
|
Series A | $20M | Biotechnology | Yes |